Analytical validation of anti-toxoplasma IgG immunoassays

Analytical validation of anti-toxoplasma IgG immunoassays

Show other versions (2)

There are often discrepancies when using different methods to measure anti-Toxoplasma gondii IgG levels in patient samples. The diagnostic performance of a chemiluminescent immunoassay (CLIA) and an enzyme-linked fluorescent assay (ELFA) used as confirmatory tests for samples identified as positive...

Full description

Bibliographic Details
Main Authors:	Guenael Freire de Souza, Darlene Carvalho, William Pedrosa, Jacqueline Franck, Renaud Piarroux
Format:	Article
Language:	English
Published:	Elsevier 2012-12-01
Series:	Brazilian Journal of Infectious Diseases
Subjects:	Toxoplasma Immunoassay ECLIA ELFA
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702012000600012

Similar Items

Analytical validation of anti-toxoplasma IgG immunoassays
by: Guenael Freire de Souza, et al.

Analytical validation of anti-toxoplasma IgG immunoassays
by: Guenael Freire de Souza, et al.
Published: (2012-11-01)

Comparison of chemiluminescent microparticle immunoassay (CMIA) with electrochemiluminescence immunoassay (ECLIA) for Carcinoembryonic antigen (CEA)
by: Nafija Serdarevic, et al.
Published: (2018-09-01)

Seroprevalence of Toxoplasma gondii in Different Patient Groups in Our Hospital
by: Fatma Esenkaya Taşbent, et al.
Published: (2022-03-01)

Comparison of the performance of three cancer antigen (CA) 15-3 immunoassays
by: Nafija Serdarevic, et al.
Published: (2016-12-01)

Long-Term Longitudinal Evaluation of Six Commercial Immunoassays for the Detection of IgM and IgG Antibodies against SARS CoV-2
by: Iulia Nedelcu, et al.
Published: (2021-06-01)

Calcitonin measurement in fine-needle aspirate washout fluid by electrochemiluminescence immunoassay for thyroid tumors
by: Minoru Kihara, et al.
Published: (2018-10-01)

Rapid detection of Salmonella sp. in pork samples using fluorescent in situ hybridization: a comparison with VIDAS®-SLM system and ISO 6579 cultural method Detecção rápida de Salmonella sp. em amostras de suinos por hibridação in situ fluorescente: comparação com o sistema VIDAS®-SLM e com o método de cultura ISO 6579
by: M. Vieira-Pinto, et al.
Published: (2007-12-01)

Results of anti-Toxoplasma gondii IgG, IgM, IgA and IgG Avidity testing in pregnant women in Rome, Italy
by: Carla Nisii, et al.
Published: (2012-12-01)

Midnight salivary cortisol, measured by highly sensitive electrochemiluminescence immunoassay, for the diagnosis of Cushing’s syndrome
by: Yaneva Maria, et al.
Published: (2009-03-01)

The Relations Between Anti-Toxoplasma IgG and IgM Antibodies With Avidity Index
by: Saeedeh Shojaee, et al.
Published: (2017-10-01)

Head-to-Head Evaluation of Five Automated SARS-CoV-2 Serology Immunoassays in Various Prevalence Settings
by: Diego O. Andrey, et al.
Published: (2021-04-01)

Prevalence of IgG and IgM anti-Toxoplasma antibodies in patients with HIV and acquired immunodeficiency syndrome (AIDS)
by: María de la Luz Galván Ramírez, et al.
Published: (1997-12-01)

The relation between serum Toxoplasma gondii IgG antibody in children and ADHD and its severity
by: İsmail Akaltun, et al.
Published: (2019-07-01)

CORRELATIONS BETWEEN CONTEMPORARY METHODS IN THE DIAGNOSIS OF CHLAMYDIA TRACHOMATIS UROGENITAL INFECTIONS.
by: Ilko Bakardzhiev, et al.
Published: (2011-10-01)

Seroprevalence of Anti-toxoplasma IgG and IgM among pregnant women attending antenatal clinic in Jos-North, Plateau State, Nigeria
by: Ocheme Okojokwu, et al.
Published: (2023-02-01)

Seropositivity of Cytomegalovirus, Rubella and Toxoplasma Gondii in Pregnant Women and IgG Avidity Tests
by: Cemal ÇİÇEK, et al.
Published: (2023-04-01)

Prevalence of anti-Toxoplasma IgG and IgM in hemodialysis patients comparing to healthy individuals in Sistan area, Iran
by: Mohammad Dorri, et al.
Published: (2017-04-01)

Frequency of anti- Toxoplasma gondii IgA, IgM, and IgG antibodies in high-risk pregnancies, in Brazil
by: Fernando Henrique Antunes Murata, et al.

Concordancia entre ELISA e IFI para la determinación de anticuerpos tipo IgG contra Toxoplasma gondii Concordance between ELISA and IFA, for IgG antibodies detection against Toxoplasma gondii
by: Liliana Jazmín Cortés, et al.
Published: (2009-06-01)

The Correlation between Serum Levels of Anti-Toxoplasma gondii Antibodies and the Risk of Diabetes
by: Maryam KHALILI, et al.
Published: (2018-12-01)

Estandarización de una prueba de inmunofluorescencia indirecta para IgG anti-Toxoplasma en ratón
by: Miriam Consuelo López, et al.
Published: (2001-03-01)

Seroprevalence of IgG and IgM antibodies against Toxoplasma gondii in pre-pregnancy women in Yazd, Iran
by: Nasser Hajipour, et al.
Published: (2023-11-01)

Evaluation of the SARS-CoV-2-IgG response in outpatients by five commercial immunoassays
by: Wellinghausen, Nele, et al.
Published: (2020-09-01)

Comparison of an Enzyme Linked-Immunosorbent Assay and a Chemiluminescent Immunoassay with an Immunofluorescence Assay for Detection of Phase II IgM and IgG Antibodies to <i>Coxiella burnetii</i>
by: Juan Francisco Gutiérrez-Bautista, et al.
Published: (2024-03-01)

Seroprevalence of IgG and IgM anti-Toxoplasma gondii antibodies and associated risks factors in pregnant women of northern Durango, Mexico
by: Rolando Adair Facio-Campos, et al.
Published: (2020-11-01)

Line immunoassay for detection of IgG antibodies to hepatitis E virus (Hepeviridae, Orthohepevirus, Orthohepevirus A)
by: G. I. Alatortseva, et al.
Published: (2020-07-01)

Serological diagnosis of Toxoplasma gondii: analysis of false-positive IgG results and implications
by: Simon Loïc, et al.
Published: (2020-01-01)

Serum Level of Anti-Toxoplasma Gondii IgG among the Individuals with/without Migraine
by: Niloufar Jouyani, et al.
Published: (2020-05-01)

Seropositivity of Anti-Toxoplasma gondii IgG among type 2 diabetes mellitus patients
by: Mays B. Jalil, et al.
Published: (2023-09-01)

Can IgG Antibodies Directed against Different Targets Solve the Problem of False-Positive Results in SARS-CoV-2 Serology?
by: Nataša Beader, et al.
Published: (2021-01-01)

Comparison of Toxoplasma gondii IgG avidity Architect and Vidas assays with the estimated date of infection in pregnant women
by: Smets Aurélie, et al.
Published: (2016-01-01)

Comparison of Rubella, Cytomegalovirus, Toxoplasma gondii seroprevalence, Still Birth and Preterm Birth Rates in Pregnant Patients Admitted to Our Hospital, IgG Avidity in IgG Positive Patients
by: Esra Gürbüz, et al.
Published: (2021-04-01)

Serological Study of IgG and IgM Antibodies to Cytomegalovirus and Toxoplasma Infections in Pregnant Women in Zakho City, Kurdistan Region, Iraq
by: Ibrahim Naqid, et al.
Published: (2019-10-01)

Two competitive enzyme immunoassays for the detection of IgG class antibodies to hepatitis a antigen
by: Claudia Lamarca Vitral, et al.
Published: (1991-06-01)

Anti-Toxoplasma IgG assays: What performances for what purpose? A systematic review
by: Robert-Gangneux Florence, et al.
Published: (2021-01-01)

The Association of <i>Toxoplasma gondii</i> IgG Antibody and Chronic Kidney Disease Biomarkers
by: Amani Babekir, et al.
Published: (2022-01-01)

Designing of ELISA kit for diagnosis of anti-Toxoplasma specific IgG, using exerted/secreted antigens and its
by: M. Kazemi, Ph.D., et al.
Published: (2008-01-01)

Seroprevalence of IgM and IgG antibodies to toxoplasma infection in human immunodeficiency virus-positive antiretroviral therapy-naive individuals
by: Saloni Garg, et al.
Published: (2019-01-01)

Genetically engineered bio-nanoparticles with co-expressed enzyme reporter and recognition element for IgG immunoassay
by: Yikun Huang, et al.
Published: (2019-12-01)